siRNA treatment decreases triglycerides in patients with rare ailment

.RESEARCH STUDY EMPHASIZE.19 September 2024.

Plozasiran lowered triglyceride amounts by 80% as well as decreased the danger of pancreatitis in clients with persistent chylomicronemia, along with or without a genetic medical diagnosis.